LOTTE BIOLOGICS Expands Global Reach with New Contract Manufacturing Deal LOTTE BIOLOGICS has secured a manufacturing deal with Ottimo Pharma to produce antibody therapeutics, marking a significant milestone for the biopharmaceutical company.

LOTTE BIOLOGICS Expands Global Reach with New Contract Manufacturing Deal #South_Korea #Seoul #Ottimo_Pharma #LOTTE_BIOLOGICS #antibody_therapeutics

LOTTE BIOLOGICS and Ottimo Pharma Join Forces for Antibody Productivity LOTTE BIOLOGICS has established a manufacturing partnership with Ottimo Pharma for innovative antibody therapeutics, marking a key step in cancer treatment advancements.

LOTTE BIOLOGICS and Ottimo Pharma Join Forces for Antibody Productivity #South_Korea #Seoul #Ottimo_Pharma #LOTTE_BIOLOGICS #Antibody_Therapies

Ottimo Pharma Appoints Veteran Leaders to Propel Unique Cancer Therapy Forward Ottimo Pharma has appointed Robert Tighe and Katherine Bell-McGuinn to enhance its leadership, advancing the innovative cancer therapy Jankistomig.

Ottimo Pharma Appoints Veteran Leaders to Propel Unique Cancer Therapy Forward #London #United_Kingdom #Leadership_Team #Ottimo_Pharma #Jankistomig

Ottimo Pharma Secures Over $140 Million in Series A Funding to Revolutionize Cancer Treatment Ottimo Pharma has raised over $140 million in Series A funding to develop innovative bifunctional cancer treatments, led by prominent investors.

Ottimo Pharma Secures Over $140 Million in Series A Funding to Revolutionize Cancer Treatment #London #cancer_therapy #United_Kingdom #Ottimo_Pharma #Jankistomig